Encephalitis (Seoul, Korea)最新文献

筛选
英文 中文
Atypical occurrence of anti-Ma2-associated encephalitis after breast cancer surgery and COVID-19. 乳腺癌手术后抗ma2相关脑炎与COVID-19的不典型发生。
Encephalitis (Seoul, Korea) Pub Date : 2023-07-01 DOI: 10.47936/encephalitis.2023.00080
Jungyun Seo, Hong Nam Kim, Minsuk Kwon, Tae-Joon Kim
{"title":"Atypical occurrence of anti-Ma2-associated encephalitis after breast cancer surgery and COVID-19.","authors":"Jungyun Seo,&nbsp;Hong Nam Kim,&nbsp;Minsuk Kwon,&nbsp;Tae-Joon Kim","doi":"10.47936/encephalitis.2023.00080","DOIUrl":"https://doi.org/10.47936/encephalitis.2023.00080","url":null,"abstract":"<p><p>In this report, we present a rare case of anti-Ma2-associated encephalitis concurrent with coronavirus disease 2019 (COVID-19) following breast cancer surgery. The patient exhibited minimal clinical symptoms of COVID-19 infection but developed seizures and altered mental status after surgery, leading to diagnosis of a classic paraneoplastic syndrome. This case highlights the possibility of paraneoplastic neurological syndrome even after cancer surgery and the need for careful consideration of post-acute infection syndromes when neurological symptoms occur following an infection.</p>","PeriodicalId":72904,"journal":{"name":"Encephalitis (Seoul, Korea)","volume":"3 3","pages":"97-101"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ce/d6/encephalitis-2023-00080.PMC10368525.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9886519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optic neuritis associated with seronegative autoimmune encephalitis: a case report. 视神经炎合并血清阴性自身免疫性脑炎1例
Encephalitis (Seoul, Korea) Pub Date : 2023-07-01 DOI: 10.47936/encephalitis.2023.00024
Hyungseok Hah, Yonghyun Lee, Ho-Won Lee, Ji-Ye Jeon
{"title":"Optic neuritis associated with seronegative autoimmune encephalitis: a case report.","authors":"Hyungseok Hah,&nbsp;Yonghyun Lee,&nbsp;Ho-Won Lee,&nbsp;Ji-Ye Jeon","doi":"10.47936/encephalitis.2023.00024","DOIUrl":"https://doi.org/10.47936/encephalitis.2023.00024","url":null,"abstract":"<p><p>Optic neuritis is an inflammatory demyelinating disorder that primarily affects the optic nerve and is often associated with multiple sclerosis. While it is rare for optic neuritis to be accompanied by autoimmune encephalitis, it can occur in some cases. A 65-year-old woman with bipolar disorder presented with a progressively altered mentality. Magnetic resonance imaging of the brain showed no definite abnormal findings. Electroencephalography revealed nonconvulsive status epilepticus. Cerebrospinal fluid study and autoimmune and paraneoplastic encephalitis antibodies were negative. The patient was diagnosed with seronegative autoimmune encephalitis and treated with methylprednisolone, intravenous immunoglobulin, and rituximab. Her condition gradually improved except for persistent blindness on the left side. This case highlights the importance of considering autoimmune encephalitis even in the absence of identifiable pathogenic antibodies when clinical manifestations and response to immunotherapy support such a diagnosis.</p>","PeriodicalId":72904,"journal":{"name":"Encephalitis (Seoul, Korea)","volume":"3 3","pages":"94-96"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e2/ad/encephalitis-2023-00024.PMC10368526.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9877420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripheral blood inflammatory cytokines in prodromal and overt α-synucleinopathies: a review of current evidence. 外周血炎症因子在前驱和显性α-突触核蛋白病中的作用:目前证据的回顾。
Encephalitis (Seoul, Korea) Pub Date : 2023-07-01 DOI: 10.47936/encephalitis.2023.00031
Jin-Sun Jun, Ryul Kim
{"title":"Peripheral blood inflammatory cytokines in prodromal and overt α-synucleinopathies: a review of current evidence.","authors":"Jin-Sun Jun,&nbsp;Ryul Kim","doi":"10.47936/encephalitis.2023.00031","DOIUrl":"https://doi.org/10.47936/encephalitis.2023.00031","url":null,"abstract":"<p><p>While the pathomechanisms of α-synucleinopathies are not completely understood, accumulating evidence suggests a role of neuroinflammation in the development and progression of the diseases. In addition, emerging data provide insights into the potential role of central neuroinflammation in prodromal α-synucleinopathies. Given the considerable bidirectional crosstalk between peripheral and central inflammation, peripheral blood inflammatory cytokines may be a useful tool to understand immune responses in association with α-synucleinopathies. Indeed, the accessibility and practicality of using blood samples have facilitated multiple investigations evaluating peripheral blood inflammatory cytokines in overt α-synucleinopathies, whereas the associations between these biomarkers and prodromal α-synucleinopathies remain unclear. In this review, we provide an overview of the current evidence available for the role of peripheral blood inflammatory cytokines in prodromal and overt α-synucleinopathies.</p>","PeriodicalId":72904,"journal":{"name":"Encephalitis (Seoul, Korea)","volume":"3 3","pages":"81-86"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1c/61/encephalitis-2023-00031.PMC10368523.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9877421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intrathecal tigecycline is a safe and effective treatment for central nervous system infections. 鞘内替加环素是一种安全有效的治疗中枢神经系统感染的方法。
Encephalitis (Seoul, Korea) Pub Date : 2023-07-01 DOI: 10.47936/encephalitis.2023.00010
Antonio Mastroianni, Valeria Vangeli, Maria Vittoria Mauro, Filippo Urso, Roberto Manfredi, Sonia Greco
{"title":"Intrathecal tigecycline is a safe and effective treatment for central nervous system infections.","authors":"Antonio Mastroianni,&nbsp;Valeria Vangeli,&nbsp;Maria Vittoria Mauro,&nbsp;Filippo Urso,&nbsp;Roberto Manfredi,&nbsp;Sonia Greco","doi":"10.47936/encephalitis.2023.00010","DOIUrl":"https://doi.org/10.47936/encephalitis.2023.00010","url":null,"abstract":"<p><p>Both the safety and effectiveness of intrathecal tigecycline (TGC) for treatment of infections of the central nervous system (CNS) are discussed using the clinical findings from a study of a recent patient who came to our attention, along with a literature review. Although penetration into the CNS is low (approximately 11%), intraventricular TGC could help treat patients with severe post- neurosurgical CNS infections. The use of multiple routes of TGC administration appears to be encouraging and should be considered in managing life-threatening intraventricular infections.</p>","PeriodicalId":72904,"journal":{"name":"Encephalitis (Seoul, Korea)","volume":"3 3","pages":"87-93"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/89/e2/encephalitis-2023-00010.PMC10368527.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9877422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The importance of ruling out herpes simplex virus encephalitis in N-methyl-ᴅ-aspartate receptor encephalitis studies. 排除单纯疱疹病毒脑炎在n -甲基-夏-天冬氨酸受体脑炎研究中的重要性。
Encephalitis (Seoul, Korea) Pub Date : 2023-07-01 DOI: 10.47936/encephalitis.2023.00101
Esma'il Akade, Shahram Jalilian, Mohammad Bahadoram
{"title":"The importance of ruling out herpes simplex virus encephalitis in N-methyl-ᴅ-aspartate receptor encephalitis studies.","authors":"Esma'il Akade,&nbsp;Shahram Jalilian,&nbsp;Mohammad Bahadoram","doi":"10.47936/encephalitis.2023.00101","DOIUrl":"https://doi.org/10.47936/encephalitis.2023.00101","url":null,"abstract":"T cell profiles in patients with N -methyl-D-aspar- tate receptor-antibody encephalitis","PeriodicalId":72904,"journal":{"name":"Encephalitis (Seoul, Korea)","volume":"3 3","pages":"79-80"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/34/ec/encephalitis-2023-00101.PMC10368524.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9886521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of convulsive status epilepticus: recent updates. 惊厥癫痫持续状态的管理:最近的更新。
Encephalitis (Seoul, Korea) Pub Date : 2023-04-01 DOI: 10.47936/encephalitis.2022.00087
Jung-Ick Byun
{"title":"Management of convulsive status epilepticus: recent updates.","authors":"Jung-Ick Byun","doi":"10.47936/encephalitis.2022.00087","DOIUrl":"https://doi.org/10.47936/encephalitis.2022.00087","url":null,"abstract":"<p><p>Convulsive status epilepticus (SE) is a medical emergency associated with high morbidity and mortality. Recently, clinical trials and meta-analyses investigating medical treatment of SE have been published. Benzodiazepine is well known as the first-line treatment for SE. Recent evidence suggests the equivalence of intravenous fosphenytoin, valproate, and levetiracetam for treatment of established SE. There is lack of evidence regarding treatment for refractory SE. Intravenous midazolam is commonly used, and recent evidence supports the use of ketamine. Additional studies are needed to improve the management of convulsive SE.</p>","PeriodicalId":72904,"journal":{"name":"Encephalitis (Seoul, Korea)","volume":"3 2","pages":"39-43"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/55/88/encephalitis-2022-00087.PMC10295829.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9835133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The use of azithromycin and pyrimethamine for treatment of cerebral toxoplasmosis in human immunodeficiency virus-infected patients: a systematic review. 使用阿奇霉素和乙胺嘧啶治疗人类免疫缺陷病毒感染患者的脑弓形虫病:一项系统综述。
Encephalitis (Seoul, Korea) Pub Date : 2023-04-01 DOI: 10.47936/encephalitis.2022.00115
Mark Erving H Ramos, Steven G Villaraza
{"title":"The use of azithromycin and pyrimethamine for treatment of cerebral toxoplasmosis in human immunodeficiency virus-infected patients: a systematic review.","authors":"Mark Erving H Ramos,&nbsp;Steven G Villaraza","doi":"10.47936/encephalitis.2022.00115","DOIUrl":"https://doi.org/10.47936/encephalitis.2022.00115","url":null,"abstract":"<p><strong>Purpose: </strong><i>Toxoplasma gondii</i> is a parasite that is widely distributed around the globe and can cause brain inflammation, particularly in immunosuppressed patients such as those diagnosed with human immunodeficiency virus (HIV). This paper reviews the efficacy of azithromycin and pyrimethamine combination therapy for cerebral toxoplasmosis in patients with HIV.</p><p><strong>Methods: </strong>The scope of the studies included in this review was limited from 1992 to 2022, with studies primarily being randomized, controlled clinical trials available on online scientific journal databases. The authors screened eligible records for review, removing those that did not fit the inclusion and exclusion criteria. The risk of bias of the extracted data was analyzed through the Cochrane risk-of-bias tool for randomized trials.</p><p><strong>Results: </strong>A broad search of major online databases such as PubMed, Medline, Google Scholar, and Cochrane using keywords, limit fields, and Boolean operators yielded 3,130 articles. After thoroughly screening the search results, two studies were included in this review. Results from the studies included in the review demonstrate that the combination therapy of azithromycin and pyrimethamine is favorable for cerebral toxoplasmosis. However, the net response is less effective than the standard treatment regimen (pyrimethamine and sulfadiazine).</p><p><strong>Conclusion: </strong>The combination therapy of azithromycin and pyrimethamine is less effective than the standard treatment regimen for maintenance therapy for cerebral toxoplasmosis; thus, administering these medications for this indication must be met with caution.</p>","PeriodicalId":72904,"journal":{"name":"Encephalitis (Seoul, Korea)","volume":"3 2","pages":"64-70"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4d/61/encephalitis-2022-00115.PMC10295825.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9835134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases. 褪黑素在神经退行性和自身免疫性中枢神经系统疾病中的神经保护作用。
Encephalitis (Seoul, Korea) Pub Date : 2023-04-01 DOI: 10.47936/encephalitis.2022.00094
Jung-Won Shin
{"title":"Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases.","authors":"Jung-Won Shin","doi":"10.47936/encephalitis.2022.00094","DOIUrl":"https://doi.org/10.47936/encephalitis.2022.00094","url":null,"abstract":"<p><p>The suprachiasmatic nucleus (SCN) in the anterior hypothalamus is the major circadian pacemaker in humans. Melatonin is a key hormone secreted by the pineal gland in response to darkness. Light-induced stimuli are transmitted along the retinohypothalamic tract to the SCN. Activation of the SCN inhibits the production of melatonin by the pineal gland through a complex neural pathway passing through the superior cervical ganglion. Accordingly, when light is unavailable, the pineal gland secretes melatonin. The circadian rhythm modulates sleep-wake cycles as well as many physiological functions of the endocrine system, including core body temperature, pulse rate, oxygen consumption, hormone levels, metabolism, and gastrointestinal function. In neurodegenerative disorders, the sleep-wake cycle is disrupted and circadian regulation is altered, which accelerates disease progression, further disrupting circadian regulation and setting up a vicious cycle. Melatonin plays a critical role in the regulation of circadian rhythms and is a multifunctional pleiotropic agent with broad neuroprotective effects in neurodegenerative disorders, viral or autoimmune diseases, and cancer. In this review, I discuss the neuroprotective functions of melatonin in circadian regulation and its roles in promoting anti-inflammatory activity, enhancing immune system functions, and preventing alterations in glucose metabolism and mitochondrial dysfunction in neurodegenerative disorders and autoimmune central nervous system diseases.</p>","PeriodicalId":72904,"journal":{"name":"Encephalitis (Seoul, Korea)","volume":"3 2","pages":"44-53"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/48/a3/encephalitis-2022-00094.PMC10295826.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9835131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protein biomarkers in multiple sclerosis. 多发性硬化症中的蛋白质生物标志物。
Encephalitis (Seoul, Korea) Pub Date : 2023-04-01 DOI: 10.47936/encephalitis.2022.00101
Jun-Soon Kim
{"title":"Protein biomarkers in multiple sclerosis.","authors":"Jun-Soon Kim","doi":"10.47936/encephalitis.2022.00101","DOIUrl":"https://doi.org/10.47936/encephalitis.2022.00101","url":null,"abstract":"<p><p>This review aimed to elucidate protein biomarkers in body fluids, such as blood and cerebrospinal fluid (CSF), to identify those that may be used for early diagnosis of multiple sclerosis (MS), prediction of disease activity, and monitoring of treatment response among MS patients. The potential biomarkers elucidated in this review include neurofilament proteins (NFs), glial fibrillary acidic protein (GFAP), leptin, brain-derived neurotrophic factor (BDNF), chitinase-3-like protein 1 (CHI3L1), C-X-C motif chemokine 13 (CXCL13), and osteopontin (OPN), with each biomarker playing a different role in MS. GFAP, leptin, and CHI3L1 levels were increased in MS patient groups compared to the control group. NFs are the most studied proteins in the MS field, and significant correlations with disease activity, future progression, and treatment outcomes are evident. GFAP CSF level shows a different pattern by MS subtype. Increased concentration of CHI3L1 in the blood/CSF of clinically isolated syndrome (CIS) is an independent predictive factor of conversion to definite MS. BDNF may be affected by chronic progression of MS. CHI3L1 has potential as a biomarker for early diagnosis of MS and prediction of disability progression, while CXCL13 has potential as a biomarker of prognosis of CIS and reflects MS disease activity. OPN was an indicator of disease severity. A periodic detailed patient evaluation should be performed for MS patients, and broadly and easily accessible biomarkers with higher sensitivity and specificity in clinical settings should be identified.</p>","PeriodicalId":72904,"journal":{"name":"Encephalitis (Seoul, Korea)","volume":"3 2","pages":"54-63"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/99/f2/encephalitis-2022-00101.PMC10295828.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9845007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Myelin oligodendrocyte glycoprotein antibody-associated encephalitis after severe acute respiratory syndrome coronavirus 2 infection: a case report and retrospective case reviews. 严重急性呼吸综合征冠状病毒2型感染后髓鞘少突胶质细胞糖蛋白抗体相关性脑炎1例报告及回顾性病例回顾
Encephalitis (Seoul, Korea) Pub Date : 2023-04-01 DOI: 10.47936/encephalitis.2022.00129
Yoonkyung Lee, Seon-Jae Ahn, Han-Sang Lee, Yongmoo Kim, Seolah Lee, Hyeyoung Park, Jangsup Moon, Sang Kun Lee, Kon Chu
{"title":"Myelin oligodendrocyte glycoprotein antibody-associated encephalitis after severe acute respiratory syndrome coronavirus 2 infection: a case report and retrospective case reviews.","authors":"Yoonkyung Lee,&nbsp;Seon-Jae Ahn,&nbsp;Han-Sang Lee,&nbsp;Yongmoo Kim,&nbsp;Seolah Lee,&nbsp;Hyeyoung Park,&nbsp;Jangsup Moon,&nbsp;Sang Kun Lee,&nbsp;Kon Chu","doi":"10.47936/encephalitis.2022.00129","DOIUrl":"https://doi.org/10.47936/encephalitis.2022.00129","url":null,"abstract":"<p><p>Several cases of myelin oligodendrocyte glycoprotein (MOG) antibody-associated encephalitis have been reported after coronavirus disease 2019 (COVID-19). In this case, the patient presented with focal status epilepticus with impaired awareness, auditory hallucinations, and incoherent speech after COVID-19. Brain magnetic resonance imaging revealed no specific findings. Cerebrospinal fluid results showed pleocytosis and MOG antibody testing confirmed anti-MOG antibody with live cell-based fluorescence-activated cell sorting assay. The patient was diagnosed with MOG antibody-associated autoimmune encephalitis and treated with intravenous immunoglobulin, rituximab, and tocilizumab. This case occurred presumably due to auto-antibody production following COVID-19.</p>","PeriodicalId":72904,"journal":{"name":"Encephalitis (Seoul, Korea)","volume":"3 2","pages":"71-77"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b8/18/encephalitis-2022-00129.PMC10295827.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9835132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信